smashing1
18 Sep 2019
Today's RNS Pharmatom/Tony, I agree with your sentiments i.e. lots of risk, and the track record isn’t good [link] . Am going to continue trying to view FUM through the eyes of LOAM.
TonyDeadeye
18 Sep 2019
Today's RNS Getting back in at the right SP is just the half of the story, smashing1. The other half (and more important half) is the current state of FUM. When the interims came out I was spitting chips to see TPR put back to February 2020, and with them saying " we expect to respond in Q1 2020 within the timelines agreed with the MHRA" it looks like the MHRA have given FUM/Thornton a whole year to respond otherwise TPR is ditched - just a guess (but a calculated guess). I know MED is the flagship product but all these failures are worrying. Plus of course the funding issue. So at present I’m struggling to see past the negatives, I’ve got a bad vibe. But don’t panic, I could be wrong (like in the past - remember TTT?) The SP does seem to be holding though which is playing further havoc in my head (ie is the Market seeing it differently). PS - Just caught your post, Pharmatom, before submitting mine. Good post. For me FUM was initially about being the ultimate multibagger and getting me early retirement, an obsession which saw me build up 250k shares. Madness now I think about it.
smashing1
18 Sep 2019
Today's RNS Mark/Tony - Just a thought. My feeling is that LOAM have tried to shake out holders since last Wednesday’s RNS. If you miss the frisson and to keep your interest, you could put back in a small/tiny part of your profit at whatever price you fancy. Or dust yourselves off and walk away.
markthemango1
17 Sep 2019
Today's RNS I agree Tony it looks like Lombard are still selling and another couple of RNS’s saying they’ve reduced their holding will decimate the SP. I just don’t think people are going to buy that many at the moment even in anticipation of results because of the need for money. No doubt it will raise back up to 40s with good results but I can only really seeing this going down for the moment with Lombard/Unsure on funding. And we’ll only know about funding once we know whether results are good are bad so it’s a big gamble, I hope it all works out for us in the end!
Aberdeen_investor
17 Sep 2019
Today's RNS Agree with the comment about buying and pissing in the wind Tony. Good luck with whatever choice you make. At the end of the day as long as you make money, that’s what counts! Don’t listen to anyone. Do what you feel is right.
TonyDeadeye
17 Sep 2019
Today's RNS I feel if I did buy back my 250k at a current cost of £75k, I probably could buy the same 250k next month for less than £40k. It’s like pissing against the wind buying at the moment. Maybe PJ could tell us what the charts are saying? Earth calling PJ. If I remember rightly, he was wrong last time so he’ll probably be right this time?!
Aberdeen_investor
17 Sep 2019
Today's RNS Well. Right now an open label is in progress. The open label is meant to be to study the safety data. However both the patients, their partners and everyone involved will know they are taking the 0.6 percent dose. This feedback may well be coming back right now and if the percentage of positive responses is higher than the standard placebo percentage response rate then you could “in theory†make your own early conclusions from it. Patients are already in this open label part. Might the Company know about the feedback already? And is this feeding into the confidence they are clearly feeling regarding the trials? I haven’t a clue but just putting it out there for discussion. My own view is that funding (hopefully non dilutive) might be announced at the same time as the headline data but what do I know. I’m just putting these shares in the bottom drawer and praying it comes good come December. Not long to go
TonyDeadeye
17 Sep 2019
Today's RNS Yes, nice one Aberdeen and hopefully my status as a FUM shareholder will have been restored by then! It’s not much fun having no FUM and some of the stock where I’ve “parked†the proceeds for the time being are quite boring. But one such stock is “Standard Life Aberdeen†(SLA) as a toast to your good self, Aberdeen! However, my patience holds firm - I don’t mind a few pence here and there but I still think those buggers Lombard will eventually grind this into the ground. Plus of course I want that funding to be addressed. Which might mean I never re-enter, I suppose. It’ll be squeeky bum time come December if FUM are trying to negotiate a fund raiser with little left - a very weak position. I just don’t get it - someone please put a positive spin on how FUM will get a decent SP raise - the Market is ruthless.
fx2452
17 Sep 2019
Today's RNS Ignore the current negative stock price ‘noise’ Mr Trump. When the 3a results come out, as mentioned, no one will be able to keep a ‘lid’ on the stock price (if the results look good). You’re right that a patent extension could possibly positively influence the stock before the 3a results. But ultimately, if those results aren’t great the extension boost would be very short lived! GLA (not too long to wait now)
Tommyl
30 Aug 2019
It seems odd to me that when speaking of a possible buyout of Fum as a company that the value of the DermaSys system is never mentioned. Is it really something special? I suspect it must be or why would T&R bother to bring out another TPR gel in a market that is loaded with them now? Could it not be used to deliver other drugs? Seems like a formidable asset unless I am missing something.
Tommyl
29 Aug 2019
Sorry for the glitch there more to the post but tough to do this with the cell phone.
Tommyl
29 Aug 2019
I have been following FUM for more than a year and finally bought shares in mid June. I have to say I have enjoyed reading all of you guy's posts going back to '16.
Tommyl
29 Aug 2019
I have been following FUM for more than a year and finally bought shares in mid June. I have to say I have enjoyed reading all of you guy's posts going back to '16
Tommyl
28 Aug 2019
Big pharmas have an extensive pipeline of drugs but none that are this much fun. I think if Med ever makes it to market the amount of recreational use by men with little or no ED issues will be massive. And if it eventually went OTC, even more so. What is not to like about an enhanced experience as reported in ph 2 trials? Everyone surely seemed to enjoy the stuff even at the low dose..
JWCJWC
11 Nov 2018
😂😂
